Chemotherapy-Induced Peripheral Neurotoxicity as A Risk Factor for Poor Sleep Quality in Breast Cancer Survivors Treated with Docetaxel.
Breast cancer
chemotherapy-induced peripheral neurotoxicity
risk factors
sleep quality
Journal
Asia-Pacific journal of oncology nursing
ISSN: 2347-5625
Titre abrégé: Asia Pac J Oncol Nurs
Pays: United States
ID NLM: 101673157
Informations de publication
Date de publication:
Historique:
received:
16
06
2020
accepted:
19
08
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
12
1
2021
Statut:
epublish
Résumé
The purpose of this study was to explore sleep quality and to determine whether chemotherapy-induced peripheral neurotoxicity is a risk factor for poor sleep quality in breast cancer survivors who receive docetaxel treatment. Secondary data analysis from a cross-sectional study. Sample characteristics were collected using an information sheet. Independent variables included the Hospital Anxiety and Depression Scale (HADS), the Patient Neurotoxicity Questionnaire (PNQ), and the Identification Pain Questionnaire (ID pain). Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). We performed descriptive analyses and simple logistic regression. A total of 98 participants were included. More than 60% of them reported poor sleep quality, with their average PSQI score being 7.54 ± 4.45. Poor subjective sleep quality (1.37 ± 0.88) and short sleep duration (1.37 ± 1.08) were their main problems. In addition, significant risk factors for poor sleep quality were chronic illness (odds ratio [OR] = 2.753, We found a high prevalence of poor sleep quality in breast cancer survivors treated with docetaxel. The results indicated that, in addition to clinical characteristics and psychological discomfort, chemotherapy-induced peripheral neurotoxicity is a significant risk factor for poor sleep quality.
Identifiants
pubmed: 33426192
doi: 10.4103/apjon.apjon_51_20
pii: S2347-5625(21)00018-4
pmc: PMC7785078
doi:
Types de publication
Journal Article
Langues
eng
Pagination
68-73Informations de copyright
Copyright: © 2020 Ann & Joshua Medical Publishing Co. Ltd.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Breast. 2017 Jun;33:125-131
pubmed: 28384563
J Clin Oncol. 2010 Jan 10;28(2):292-8
pubmed: 19933917
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Sleep Breath. 2020 Mar;24(1):241-251
pubmed: 31016572
Support Care Cancer. 2019 Dec;27(12):4401-4433
pubmed: 31346744
Sleep Med. 2017 Apr;32:208-212
pubmed: 28366336
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur J Cancer. 2015 Feb;51(3):292-300
pubmed: 25541155
Eur J Oncol Nurs. 2016 Dec;25:16-23
pubmed: 27865248
Support Care Cancer. 2012 Feb;20(2):357-65
pubmed: 21311913
Curr Med Res Opin. 2006 Aug;22(8):1555-65
pubmed: 16870080
Hong Kong Med J. 2011 Aug;17(4):297-300
pubmed: 21813898
Breast. 2014 Dec;23(6):697-709
pubmed: 25307946
Curr Oncol. 2014 Aug;21(4):174-80
pubmed: 25089099
Support Care Cancer. 2013 Dec;21(12):3307-13
pubmed: 23903798
Semin Oncol. 2006 Feb;33(1):15-49
pubmed: 16473643
Support Care Cancer. 2015 May;23(5):1401-8
pubmed: 25370891
Support Care Cancer. 2009 Dec;17(12):1483-91
pubmed: 19330359
Breast Cancer Res Treat. 2017 Jun;163(2):331-342
pubmed: 28258353
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nat Sci Sleep. 2017 May 19;9:151-161
pubmed: 28579842
Support Care Cancer. 2013 Apr;21(4):959-67
pubmed: 23052918
Toxics. 2015 Apr 28;3(2):152-169
pubmed: 29056655
Qual Life Res. 2018 Aug;27(8):2077-2086
pubmed: 29740782
Breast Cancer Res Treat. 2016 Sep;159(2):327-33
pubmed: 27510185
Eur J Cancer Care (Engl). 2015 Jul;24(4):553-9
pubmed: 25727241
Pain. 2016 Mar;157(3):560-8
pubmed: 26529271
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 26786536
Nat Sci Sleep. 2012 Dec 17;4:151-162
pubmed: 23486503
Support Care Cancer. 2013 Jan;21(1):43-51
pubmed: 22584732